Human epidermal growth factor receptor 2 (HER2) and triple-negative breast cancer (TNBC) are the most aggressive breast cancer molecular subtypes, associated with the highest frequency of recurrence and poorer outcomes [14,15]. This evidence concerns the gene ERBB2 and breast carcinoma.